Marico raises Cosmix Wellness stake to 80% with ₹114 crore cash deal
- Mergers & acquisitions
- Personal Care
Reviewed byKeshav SehgalBlacklitt Research
Marico (NSE: MARICO) has completed the acquisition of a further 20% stake in Cosmix Wellness Private Limited for ₹113.65 crore in cash, taking its holding from 60% to 80%, it said in a filing on 06 Nov 2026. The transaction is a related party transaction on an arm's length basis.
Key highlights
- Consideration for 20% stake: ₹113.65 crore, cash
- Aggregate stake: 60% to 80% of paid-up share capital
- Acquisition completed on 06 Nov 2026
- Cosmix Wellness turnover FY 2025-26: ₹91.53 crore
The acquisition in numbers
| Item | Detail |
|---|---|
| Target | Cosmix Wellness Private Limited, Bengaluru |
| Stake acquired | 20% of paid-up share capital |
| Stake after acquisition | 80%, up from 60% |
| Consideration | ₹113.65 crore, cash |
| Completion date | 06 Nov 2026 |
| Related party status | Related party transaction, arm's length basis |
Stake and price of the further 20%
Marico has raised its aggregate stake in Cosmix Wellness from 60% to 80% of its paid-up share capital by acquiring a further 20% under a definitive agreement. The company said the acquisition was completed on 06 Nov 2026 and that the consideration of ₹113.65 crore was paid in cash.
The earlier 60% stake was acquired from the founders of Cosmix Wellness, following letters Marico sent to the exchanges on 04 Feb 2026 and 05 Feb 2026. The filing does not name the sellers of the further 20%.
Cosmix Wellness and its recent turnover
Cosmix Wellness was incorporated under the Companies Act, 2013 on 31 Jan 2022 and is headquartered in Bengaluru. The company describes it as owning one of India's leading digital-first functional wellness brands.
Turnover reported in the annexure rose from ₹24.32 crore in FY 2023-24 to ₹47.25 crore in FY 2024-25 and ₹91.53 crore in FY 2025-26. The company states that the last three months' ARR under Ind AS is over ₹170 crore, which is about 1.9 times the FY 2025-26 turnover.
Fit with Marico's portfolio and recent filings
Marico says the acquisition has expanded its presence in premium food and nutrition categories. Against the company's latest consolidated total income of ₹3,950.00 crore in Q2 FY27, the ₹113.65 crore consideration is a small step, though the filing does not give the impact on Marico's results.
The filing follows Marico's results filing of 02 Nov 2026, which reported consolidated net profit of ₹558.00 crore for the quarter.
What the Cosmix Wellness stake means for Marico's shareholders
Marico's holding in a subsidiary rises to 80% after a cash outlay of ₹113.65 crore.
Not stated: the valuation basis for the price, the effect on Marico's financial results, and the terms and timing of the right to acquire the remaining stake after FY29, which will depend on milestones and approvals not yet defined.
Filed with NSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.